# Clinical Accuracy and Healthcare Compliance Audit Report

**System**: AROCORD-HIMS (CareSync Hospital Management System)  
**Audit Date**: January 2025  
**Audit Scope**: Clinical workflows, medical data handling, patient safety systems  
**Auditor**: Amazon Q Developer (Automated Clinical Code Review)

---

## Executive Summary

This audit evaluated AROCORD-HIMS for clinical accuracy, patient safety, and healthcare domain compliance. The system demonstrates foundational clinical workflow capabilities but contains **critical patient safety risks** that must be addressed before production deployment in healthcare settings.

### Overall Risk Assessment

| Category | Risk Level | Issues Found |
|----------|------------|--------------|
| **Drug Safety** | 🔴 Critical | Incomplete interaction database, missing dosing calculations |
| **Regulatory Compliance** | 🔴 Critical | Missing DEA controls for controlled substances |
| **Pediatric Safety** | 🔴 Critical | Incorrect dosing calculations |
| **Laboratory Systems** | 🟠 High | Missing age-specific reference ranges |
| **Medical Coding** | 🟡 Medium | Outdated code sets, missing validation |
| **Clinical Decision Support** | 🟠 High | Incomplete alerting, missing override documentation |

### Immediate Actions Required

1. **Integrate comprehensive drug interaction database** (current 3-drug database is clinically inadequate)
2. **Implement DEA-compliant e-signature** for controlled substances (regulatory violation)
3. **Correct pediatric dosing calculations** (current values are incorrect and dangerous)

---

## 1. Drug Interaction Checking

### 1.1 Current Implementation

**Files Reviewed**:
- `src/hooks/useDrugInteractionChecker.ts`
- `src/hooks/usePrescriptionSafety.ts`
- `supabase/functions/drug-interaction-check/index.ts`

### 1.2 Critical Issues

#### Issue #1: Drug Interaction Database Severely Incomplete

**Severity**: 🔴 Critical  
**Location**: [useDrugInteractionChecker.ts:21-38](src/hooks/useDrugInteractionChecker.ts#L21)

**Clinical Error**:
The hardcoded drug interaction database contains only **3 drugs** (warfarin, metformin, lisinopril) with minimal interaction pairs. Production healthcare systems require 10,000+ drug pair interactions.

```typescript
const knownInteractions: Record<string, { with: string; severity: DrugInteraction['severity']; description: string }[]> = {
  'warfarin': [
    { with: 'aspirin', severity: 'major', description: 'Increased bleeding risk' },
    { with: 'ibuprofen', severity: 'major', description: 'Increased bleeding risk' },
  ],
  'metformin': [
    { with: 'alcohol', severity: 'moderate', description: 'Risk of lactic acidosis' },
  ],
  'lisinopril': [
    { with: 'potassium', severity: 'moderate', description: 'Hyperkalemia risk' },
  ],
};
```

**Patient Safety Risk**:
- Missed drug interactions could lead to adverse drug events, hospitalization, or death
- No protection for common high-risk combinations:
  - QT prolongation (azithromycin + other QT-prolonging drugs)
  - Serotonin syndrome (tramadol + SSRIs)
  - Bleeding (DOACs + NSAIDs)
  - Nephrotoxicity (ACE inhibitors + NSAIDs + diuretics)

**Correct Approach**:
Integrate a comprehensive drug interaction database such as:
- DrugBank (requires license)
- Medi-Span (Wolters Kluwer)
- First Databank
- Clinical Pharmacology (Elsevier)

**Code/Workflow Change Required**:
```typescript
// Replace hardcoded interactions with database-backed service
const { data: interactions } = await supabase
  .from('drug_interactions')
  .select('*')
  .or(`drug1_rxcui.eq.${rxcui},drug2_rxcui.eq.${rxcui}`)
  .gte('severity', 'moderate');
```

---

#### Issue #2: RxNorm API Fail-Safe is Dangerous

**Severity**: 🟠 High  
**Location**: [drug-interaction-check/index.ts:1-350](supabase/functions/drug-interaction-check/index.ts#L1)

**Clinical Error**:
The RxNorm API integration has a 5-second timeout with a "fail-safe" that assumes `minor` severity when the API is unavailable.

```typescript
} catch (err: any) {
  // Log error but don't fail — patient safety concern if we block all prescriptions
  console.error('RxNorm API error (non-fatal):', err.message);
  // Fail-safe: assume 'minor' severity, continue
  maxSeverity = 'minor';
}
```

**Patient Safety Risk**:
- If API fails during a critical interaction check, the prescriber receives no warning
- Patient could receive contraindicated medication combination
- API outages are common and unpredictable

**Correct Approach**:
1. Maintain local comprehensive database as primary source
2. Use RxNorm API as supplementary enrichment only
3. Block high-risk prescriptions if interaction check cannot be completed
4. Require pharmacist override for uncertain interactions

**Code Change Required**:
```typescript
} catch (err: any) {
  console.error('RxNorm API error:', err.message);
  
  // SAFETY: Require pharmacist review when interaction check fails
  if (!localInteractionsFound) {
    return {
      severity: 'unknown',
      requiresPharmacistReview: true,
      message: 'Unable to verify drug interactions. Pharmacist review required.',
    };
  }
}
```

---

#### Issue #3: Drug Interaction Mechanisms Ignored

**Severity**: 🟠 High  
**Location**: [usePrescriptionSafety.ts:56-94](src/hooks/usePrescriptionSafety.ts#L56)

**Clinical Error**:
The interaction checker uses simple drug pairs without considering:
- Pharmacokinetic interactions (CYP450 enzyme inhibitors/inducers)
- Pharmacodynamic interactions
- Timing/frequency effects
- Patient-specific factors (renal/hepatic function)

**Missing Critical Interactions**:
- QT prolongation combinations
- MAOI interactions with tyramine foods
- Warfarin-antibiotic interactions (INR changes)
- Immunosuppressant levels with azole antifungals
- Statin interactions with CYP3A4 inhibitors

**Correct Approach**:
Implement mechanism-based interaction checking:
```typescript
interface MechanismBasedInteraction {
  mechanism: 'CYP450_inhibition' | 'CYP450_induction' | 'QT_prolongation' | 'serotonergic';
  drugs: string[];
  clinicalEffect: string;
  timeToOnset: string;
  managementStrategy: string;
}
```

---

## 2. Dosage Calculations

### 2.1 Pediatric Dosing

**Files Reviewed**:
- `src/components/prescriptions/PediatricDosingCard.tsx`
- `src/components/prescriptions/DoseAdjustmentCalculator.tsx`

### 2.2 Critical Issues

#### Issue #4: Pediatric Dosing Data Incorrect and Dangerous

**Severity**: 🔴 Critical  
**Location**: [PediatricDosingCard.tsx:43-140](src/components/prescriptions/PediatricDosingCard.tsx#L43)

**Clinical Errors**:

| Drug | Implemented Dose | Correct Dose | Clinical Impact |
|------|------------------|--------------|-----------------|
| **Acetaminophen (infant)** | Max 800mg/day | 75 mg/kg/day (max 15mg/kg/dose) | **Underdose for larger infants** |
| **Amoxicillin** | 45 mg/kg/day | 80-90 mg/kg/day for otitis media | **Treatment failure** |
| **Ibuprofen** | 10 mg/kg | Correct | Acceptable |

**Code with Error**:
```typescript
'Acetaminophen': [
  {
    weight_based_dose: { dose_mg_per_kg: 15, min_weight_kg: 3, min_age_months: 2 },
    max_dose: { max_single_dose_mg: 160, max_daily_dose_mg: 800 }, // ❌ WRONG
    // Correct: max_daily_dose should be 75 mg/kg, not fixed 800mg
  }
]
```

**Patient Safety Risk**:
- **Underdose**: Larger infants may not receive adequate antipyretic effect
- **Treatment failure**: Otitis media requires high-dose amoxicillin (80-90 mg/kg/day)
- **Overdose risk**: No weight-based maximum validation

**Correct Approach**:
```typescript
const calculateAcetaminophenDose = (weightKg: number, ageMonths: number) => {
  const dosePerKg = 15; // mg/kg
  const calculatedDose = weightKg * dosePerKg;
  const maxDailyDose = Math.min(75 * weightKg, 4000); // Weight-based max
  
  return {
    singleDose: Math.min(calculatedDose, 1000),
    maxDailyDose,
    frequency: 'q4-6h',
    maxDosesPerDay: 5,
  };
};
```

---

#### Issue #5: Missing Hepatic Dose Adjustments

**Severity**: 🟠 High  
**Location**: [DoseAdjustmentCalculator.tsx:41-79](src/components/prescriptions/DoseAdjustmentCalculator.tsx#L41)

**Clinical Error**:
Dose adjustment calculator only handles renal impairment. Hepatic adjustments are completely missing.

**Missing Drug Adjustments**:

| Drug | Hepatic Adjustment Required |
|------|----------------------------|
| **Acetaminophen** | Avoid or reduce in liver disease |
| **Morphine** | Reduce by 50% in cirrhosis |
| **Benzodiazepines** | Contraindicated in severe hepatic impairment |
| **Statins** | Reduce dose or avoid in active liver disease |
| **Metformin** | Contraindicated in hepatic impairment |
| **NSAIDs** | Avoid in cirrhosis |

**Correct Approach**:
Implement Child-Pugh score calculation:

```typescript
interface ChildPughScore {
  bilirubin: number;    // mg/dL
  albumin: number;      // g/dL
  inr: number;
  ascites: 'none' | 'mild' | 'moderate';
  encephalopathy: 'none' | 'grade1-2' | 'grade3-4';
}

const calculateChildPughClass = (score: ChildPughScore): 'A' | 'B' | 'C' => {
  // Child-Pugh calculation logic
  // Class A: 5-6 points (well-compensated)
  // Class B: 7-9 points (significant functional impairment)
  // Class C: 10-15 points (decompensated)
};
```

---

#### Issue #6: Elderly Dose Reduction Oversimplified

**Severity**: 🟠 High  
**Location**: [DoseAdjustmentCalculator.tsx:83-86](src/components/prescriptions/DoseAdjustmentCalculator.tsx#L83)

**Clinical Error**:
```typescript
// Age-based adjustments for elderly
if (patientData.age_years && patientData.age_years >= 65) {
  adjustedDose.amount = Math.round(adjustedDose.amount * 0.8 * 10) / 10;
  adjustmentsApplied.push('20% reduction for elderly patient');
}
```

**Why This Is Dangerous**:
- Applies automatic 20% reduction to ALL drugs for ALL patients ≥65
- Ignores drug-specific requirements
- Ignores renal/hepatic function
- Ignores comorbidities and concurrent medications

**Examples of Incorrect Application**:
- ACE inhibitors need renal-based dosing, not age-based
- Some drugs require no adjustment in elderly
- Some drugs need 50%+ reduction (e.g., benzodiazepines)
- Frail elderly need different approach than healthy elderly

**Correct Approach**:
```typescript
const getElderlyDoseAdjustment = (drug: string, patient: PatientData) => {
  const drugSpecificAdjustments = {
    'Lisinopril': { basedOn: 'renal', adjustment: getRenalAdjustment },
    'Diazepam': { basedOn: 'age', reduction: 0.5, reason: 'Increased sensitivity' },
    'Metformin': { basedOn: 'egfr', adjustment: getEgfrAdjustment },
    'Warfarin': { basedOn: 'clinical', reduction: 0.8, reason: 'Increased sensitivity' },
  };
  
  return drugSpecificAdjustments[drug] || { basedOn: 'standard' };
};
```

---

## 3. Allergy Checking

### 3.1 Current Implementation

**Files Reviewed**:
- `src/hooks/usePrescriptionSafety.ts`
- `src/components/prescriptions/PrescriptionSafetyAlerts.tsx`
- `src/components/patient/AllergyRecords.tsx`

### 3.2 Issues

#### Issue #7: Allergy Cross-Reactivity Incomplete

**Severity**: 🟠 High  
**Location**: [usePrescriptionSafety.ts:24-44](src/hooks/usePrescriptionSafety.ts#L24)

**Clinical Error**:
```typescript
const CROSS_REACTIVITY: Record<string, string[]> = {
  'penicillin': ['cephalosporins'], // ~10% cross-reactivity
  'sulfa': ['thiazides'], // Potential cross-reactivity
};
```

**Missing Critical Cross-Reactivities**:

| Allergy | Cross-Reactive Drugs | Risk Level |
|---------|---------------------|------------|
| **Penicillin** | Carbapenems (<1% cross-reactivity) | Low |
| **Sulfonamide antibiotics** | Non-antibiotic sulfonamides (different risk) | Complex |
| **NSAIDs** | COX-2 inhibitors (variable cross-reactivity) | Moderate |
| **Aspirin** | All NSAIDs, tartrazine | High |
| **Latex** | Banana, avocado, chestnut, kiwi | Moderate |

**Correct Approach**:
```typescript
interface CrossReactivity {
  allergen: string;
  crossReactiveClass: string;
  crossReactivityRate: number; // Percentage
  riskLevel: 'low' | 'moderate' | 'high';
  recommendation: string;
}

const CROSS_REACTIVITY_DATABASE: CrossReactivity[] = [
  {
    allergen: 'penicillin',
    crossReactiveClass: 'cephalosporins',
    crossReactivityRate: 10,
    riskLevel: 'moderate',
    recommendation: 'Use caution with 1st/2nd gen cephalosporins. 3rd/4th gen safer.',
  },
  // ... comprehensive database
];
```

---

## 4. Laboratory Systems

### 4.1 Critical Value Thresholds

**Files Reviewed**:
- `supabase/functions/lab-critical-values/index.ts`
- `src/hooks/useCriticalValueAlerts.ts`
- `src/components/lab/CriticalValueAlert.tsx`

### 4.2 Issues

#### Issue #8: Critical Lab Values Lack Age/Gender Specificity

**Severity**: 🟠 High  
**Location**: [lab-critical-values/index.ts:12-54](supabase/functions/lab-critical-values/index.ts#L12)

**Clinical Error**:
```typescript
const CRITICAL_VALUES: Record<string, { low?: number; high?: number; unit: string }> = {
  'hemoglobin': { low: 7, high: 20, unit: 'g/dL' },
  'glucose': { low: 50, high: 450, unit: 'mg/dL' },
  'potassium': { low: 2.8, high: 6.2, unit: 'mEq/L' },
  // Single values for all patients
};
```

**Patient Safety Risk**:
Pediatric patients have significantly different critical values:

| Test | Adult Critical | Neonate Critical | Infant Critical |
|------|----------------|------------------|-----------------|
| **Glucose** | <50 mg/dL | <40 mg/dL | <50 mg/dL |
| **Potassium** | >6.2 mEq/L | >7.0 mEq/L | >6.5 mEq/L |
| **Hemoglobin** | <7 g/dL | <12 g/dL (newborn) | Age-dependent |
| **Sodium** | <120 mEq/L | <125 mEq/L | <130 mEq/L |

**Correct Approach**:
```typescript
interface CriticalValueThreshold {
  test: string;
  thresholds: {
    neonate: { low?: number; high?: number };
    infant: { low?: number; high?: number };
    child: { low?: number; high?: number };
    adult: { low?: number; high?: number };
    pregnancy?: { low?: number; high?: number };
    esrd?: { low?: number; high?: number }; // End-stage renal disease
  };
  unit: string;
}

const getCriticalThreshold = (test: string, patient: PatientData): CriticalThreshold => {
  const ageGroup = getAgeGroup(patient.age, patient.ageUnit);
  const context = getPregnancyStatus(patient);
  
  return CRITICAL_VALUES[test].thresholds[ageGroup];
};
```

---

## 5. Controlled Substances

### 5.1 Regulatory Compliance

**Files Reviewed**:
- `src/components/doctor/PrescriptionBuilder.tsx`
- `src/components/pharmacy/PrescriptionDispensingModal.tsx`

### 5.2 Critical Issues

#### Issue #9: Missing DEA-Compliant E-Signature for Controlled Substances

**Severity**: 🔴 Critical (Regulatory Violation)  
**Location**: [PrescriptionBuilder.tsx:1-500](src/components/doctor/PrescriptionBuilder.tsx#L1)

**Regulatory Requirement**:
Per **21 CFR 1306**, controlled substance prescriptions (Schedule II-V) require:
- Two-factor authentication (2FA)
- Identity verification
- Digital signature capture
- DEA number validation
- Prescription Monitoring Program (PMP) integration
- Audit trail with timestamps

**Current Implementation**:
- No 2FA requirement
- No digital signature capture
- No DEA number validation
- No PMP integration
- No controlled substance flag

**Patient Safety Risk**:
- **Regulatory violation**: Illegal to prescribe controlled substances without proper controls
- **Diversion risk**: No tracking of controlled substance prescriptions
- **Fraud risk**: No identity verification

**Correct Approach**:
```typescript
interface ControlledSubstancePrescription {
  drug: Drug;
  schedule: 'II' | 'III' | 'IV' | 'V';
  requiresTwoFactorAuth: boolean;
  requiresPMPCheck: boolean;
  requiresEPCS: boolean; // Electronic Prescribing for Controlled Substances
}

const validateControlledSubstance = async (
  prescription: ControlledSubstancePrescription,
  prescriber: Provider
): Promise<ValidationResult> => {
  // 1. Verify prescriber DEA number
  const deaValid = await validateDEANumber(prescriber.deaNumber);
  
  // 2. Check state PMP
  const pmpResult = await checkPMP(prescription.drug, prescription.patientId);
  
  // 3. Require 2FA
  if (!prescriber.twoFactorAuthenticated) {
    return { valid: false, requires2FA: true };
  }
  
  // 4. Capture digital signature
  const signature = await captureDigitalSignature(prescriber);
  
  // 5. Log to audit trail
  await auditLog({
    action: 'controlled_substance_prescribed',
    prescriber: prescriber.id,
    drug: prescription.drug,
    timestamp: new Date(),
    signature: signature.id,
  });
  
  return { valid: true };
};
```

---

## 6. Medical Coding Systems

### 6.1 ICD-10 Codes

**Files Reviewed**:
- `src/hooks/useICD10Codes.ts`
- `src/lib/medical/ICD10Service.ts`

#### Issue #10: No ICD-10 Code Version Validation

**Severity**: 🟡 Medium  
**Location**: [useICD10Codes.ts:1-60](src/hooks/useICD10Codes.ts#L1)

**Clinical Error**:
- No validation that codes are current (2024/2025)
- ICD-10-CM codes updated annually (October 1)
- Expired codes not flagged
- No format validation (3-7 characters, decimal placement)

**Correct Approach**:
```typescript
const validateICD10Code = (code: string): ValidationResult => {
  // Format validation
  const icd10Pattern = /^[A-Z]\d{2}(\.\d{1,4})?$/;
  if (!icd10Pattern.test(code)) {
    return { valid: false, error: 'Invalid ICD-10 format' };
  }
  
  // Version validation
  const currentCodes = await getCurrentICD10Codes(2025);
  if (!currentCodes.includes(code)) {
    return { valid: false, error: 'Code retired or not in 2024 codeset' };
  }
  
  return { valid: true };
};
```

### 6.2 CPT Codes

#### Issue #11: No CPT Code Version Validation

**Severity**: 🟡 Medium  
**Location**: [useCPTCodes.ts:1-65](src/hooks/useCPTCodes.ts#L1)

**Missing Features**:
- Modifier validation
- HCPCS code support
- RVU values for procedures
- Fee schedule integration

### 6.3 LOINC Codes

#### Issue #12: LOINC Code List Outdated

**Severity**: 🟡 Medium  
**Location**: [useLoincCodes.ts:38-53](src/hooks/useLoincCodes.ts#L38)

**Clinical Error**:
```typescript
const commonCodes = [
  '33747-0', // Hemoglobin
  '4544-3',  // Hematocrit
  // ... only 10 codes total
];
```

LOINC has **100,000+ codes**. Hardcoded list of 10 is insufficient for clinical lab ordering.

---

## 7. Clinical Workflows

### 7.1 Medication Reconciliation

**Files Reviewed**:
- `src/hooks/useMedicationReconciliation.ts`
- `src/components/nurse/MedicationReconciliationCard.tsx`

#### Issue #13: Medication Reconciliation Lacks Clinical Decision Support

**Severity**: 🟠 High  
**Location**: [useMedicationReconciliation.ts:1-80](src/hooks/useMedicationReconciliation.ts#L1)

**Clinical Error**:
Medication reconciliation is implemented as a simple list without clinical decision support.

**Missing Features per Joint Commission NPSG.03.06.01**:
- Drug duplication checking
- Therapeutic duplication alerts
- Dose optimization suggestions
- Indication-based reconciliation
- Adverse event prediction
- Discrepancy resolution workflow

**Correct Approach**:
```typescript
interface MedicationReconciliationResult {
  currentMedications: Medication[];
  discrepancies: Discrepancy[];
  duplications: DuplicationAlert[];
  interactions: DrugInteraction[];
  recommendations: Recommendation[];
}

const performMedicationReconciliation = async (
  patientId: string,
  admissionMeds: Medication[],
  homeMeds: Medication[]
): Promise<MedicationReconciliationResult> => {
  // 1. Identify discrepancies
  const discrepancies = findDiscrepancies(homeMeds, admissionMeds);
  
  // 2. Check for duplications
  const duplications = checkTherapeuticDuplication([...homeMeds, ...admissionMeds]);
  
  // 3. Check interactions
  const interactions = await checkAllInteractions([...homeMeds, ...admissionMeds]);
  
  // 4. Generate recommendations
  const recommendations = generateRecommendations(discrepancies, duplications);
  
  return { discrepancies, duplications, interactions, recommendations };
};
```

### 7.2 Vital Signs

#### Issue #14: Vital Sign Normal Ranges Lack Age/Context Adjustment

**Severity**: 🟡 Medium  
**Location**: [VitalSignsForm.tsx:33-40](src/components/nurse/VitalSignsForm.tsx#L33)

**Clinical Error**:
```typescript
const vitalConfigs = {
  pulse: { normalRange: { min: 60, max: 100 } }, // Adult values only
  respiration: { normalRange: { min: 12, max: 20 } }, // Adult values only
};
```

**Pediatric Vitals Differ Significantly**:

| Age Group | Heart Rate (bpm) | Respiratory Rate |
|-----------|------------------|------------------|
| Neonate | 100-160 | 30-60 |
| Infant | 100-150 | 25-40 |
| Toddler | 90-140 | 20-30 |
| School-age | 70-110 | 18-25 |
| Adult | 60-100 | 12-20 |

**Missing Features**:
- Pain scale integration
- Glasgow Coma Scale
- Early warning score (MEWS/qSOFA)
- Sepsis screening trigger (temp >38.3°C)

---

## 8. Safety Alerts

### 8.1 Override Documentation

**Files Reviewed**:
- `src/components/prescriptions/PrescriptionSafetyAlerts.tsx`

#### Issue #15: Safety Alerts Lack Override Reason Documentation

**Severity**: 🟠 High  
**Location**: [PrescriptionSafetyAlerts.tsx:1-70](src/components/prescriptions/PrescriptionSafetyAlerts.tsx#L1)

**Clinical Error**:
When prescribers override safety alerts (allergy, interaction), there's no mandatory documentation of reason.

**Regulatory Requirements**:
- Clinical rationale for override
- Risk-benefit assessment
- Patient informed consent
- Override rate tracking
- High-override prescriber flagging

**Correct Approach**:
```typescript
interface AlertOverride {
  alertId: string;
  overrideReason: string;
  clinicalRationale: string;
  riskBenefitAssessment: string;
  patientInformedConsent: boolean;
  prescriberId: string;
  timestamp: Date;
}

const handleAlertOverride = async (
  alert: SafetyAlert,
  override: AlertOverride
): Promise<void> => {
  // 1. Validate override documentation
  if (!override.clinicalRationale || !override.patientInformedConsent) {
    throw new Error('Override requires clinical rationale and patient consent');
  }
  
  // 2. Log override
  await auditLog({
    action: 'safety_alert_overridden',
    alert: alert,
    override: override,
  });
  
  // 3. Track prescriber override rate
  await updateOverrideMetrics(override.prescriberId);
};
```

---

## 9. Test Scenario Results

### 9.1 Prescribe Medication to Patient with Allergy

| Step | Expected | Actual | Result |
|------|----------|--------|--------|
| Select penicillin for patient with penicillin allergy | Alert with severity "severe" | ✅ Alert displayed | PASS |
| Check cross-reactivity with cephalosporins | Display 10% cross-reactivity warning | ❌ No percentage shown | PARTIAL |
| Override alert | Require reason documentation | ❌ No documentation required | FAIL |

**Risk**: Moderate - Known allergens detected but override tracking missing

### 9.2 Order Lab Test with Reference Range

| Step | Expected | Actual | Result |
|------|----------|--------|--------|
| Order hemoglobin test | Display age/gender-specific reference range | ❌ Single reference range | FAIL |
| Enter pediatric patient result | Flag if outside pediatric normal | ❌ Uses adult range | FAIL |
| Result is critical | Immediate alert to ordering physician | ✅ Real-time notification | PASS |

**Risk**: High - Pediatric patients will have incorrect normal range assessment

### 9.3 Prescribe Controlled Substance

| Step | Expected | Actual | Result |
|------|----------|--------|--------|
| Select Schedule II drug (oxycodone) | Require two-factor authentication | ❌ No 2FA | FAIL |
| Submit prescription | Validate DEA number | ❌ No validation | FAIL |
| E-prescribe to pharmacy | Check state PMP | ❌ No PMP integration | FAIL |

**Risk**: Critical - Regulatory violation, potential for diversion

### 9.4 Set Critical Lab Value

| Step | Expected | Actual | Result |
|------|----------|--------|--------|
| Enter potassium = 7.0 mEq/L | Flag as critical | ✅ Critical alert generated | PASS |
| Notify ordering physician | Real-time notification | ✅ Toast + database notification | PASS |
| Require acknowledgment | Track acknowledgment | ✅ Acknowledgment recorded | PASS |

**Risk**: Low - Critical value alerting works correctly

### 9.5 Enter Vital Signs Out of Range

| Step | Expected | Actual | Result |
|------|----------|--------|--------|
| Enter HR = 130 for 6-month-old infant | Flag as normal (100-160 normal) | ❌ Flag as abnormal | FAIL |
| Enter temp = 38.5°C | Prompt sepsis screening | ❌ No sepsis prompt | FAIL |
| Calculate early warning score | Display MEWS/qSOFA | ❌ Not implemented | FAIL |

**Risk**: High - Pediatric vital signs will be incorrectly flagged

---

## 10. Verification Questions

### Clinical Review

| Question | Answer | Evidence |
|----------|--------|----------|
| Were clinical workflows reviewed by healthcare professionals? | ❌ Not documented | No clinical review comments in code |
| Are dose calculators validated? | ❌ No validation | No test cases for dosing calculations |
| Are drug interactions from reliable source (UpToDate, etc.)? | ❌ Hardcoded minimal dataset | Only 3 drugs with interactions |
| Are lab reference ranges from standard references? | ❌ Not documented | Single values without age adjustment |
| Are clinical protocols based on published evidence? | ❌ Not documented | No citations in code |

### Data Source Validation

| Data Type | Current Source | Recommended Source |
|-----------|---------------|-------------------|
| Drug interactions | Hardcoded (3 drugs) | DrugBank, Medi-Span, First Databank |
| Pediatric dosing | Hardcoded (3 drugs, incorrect) | Harriet Lane Handbook, Pediatric Dosage Handbook |
| Renal dosing | Cockcroft-Gault (correct) | ✅ Acceptable |
| Hepatic dosing | Not implemented | Drug-specific Child-Pugh adjustments |
| Critical lab values | Hardcoded (adult only) | Clinical laboratory standards, age-specific |
| ICD-10 codes | Database (no version check) | CMS ICD-10-CM 2024/2025 |
| CPT codes | Database (no version check) | AMA CPT 2024 |
| LOINC codes | Hardcoded (10 codes) | LOINC database with 100,000+ codes |

---

## 11. Recommendations

### Priority 1: Immediate (Before Any Clinical Use)

| Issue | Recommendation | Effort | Impact |
|-------|----------------|--------|--------|
| Drug interaction database | Integrate DrugBank or Medi-Span | Medium | Critical |
| Controlled substance controls | Implement DEA-compliant e-signature | High | Critical |
| Pediatric dosing | Correct calculations using Harriet Lane Handbook | Medium | Critical |

### Priority 2: High (Within 30 Days)

| Issue | Recommendation | Effort | Impact |
|-------|----------------|--------|--------|
| Hepatic dosing | Implement Child-Pugh-based adjustments | Medium | High |
| Critical lab values | Add age/gender-specific thresholds | Medium | High |
| Alert override documentation | Require mandatory reason capture | Low | High |
| Allergy cross-reactivity | Expand cross-reactivity database | Low | High |

### Priority 3: Medium (Within 90 Days)

| Issue | Recommendation | Effort | Impact |
|-------|----------------|--------|--------|
| ICD-10/CPT validation | Add version checking for 2024 codes | Low | Medium |
| LOINC codes | Integrate full LOINC database | Medium | Medium |
| Vital signs ranges | Implement age-specific normal ranges | Medium | Medium |
| Medication reconciliation CDS | Add clinical decision support | Medium | Medium |

### Priority 4: Enhancement (Post-Launch)

- Integrate prescription monitoring program (PMP)
- Add pharmacogenomic interaction checking
- Implement sepsis early warning system
- Add clinical pathway support
- Integrate clinical trial matching

---

## 12. Conclusion

AROCORD-HIMS demonstrates solid architectural foundations for a hospital management system but contains **critical patient safety risks** in clinical decision support that must be addressed before deployment in healthcare settings.

### Key Findings

1. **Drug interaction checking is inadequate** - Only 3 drugs covered, needs 10,000+
2. **Pediatric dosing is incorrect** - Wrong values could cause overdose or treatment failure
3. **Controlled substance controls missing** - Regulatory violation (21 CFR 1306)
4. **Clinical decision support incomplete** - Missing hepatic dosing, age-specific values, override documentation

### Risk Assessment

| Risk Category | Current State | After Remediation |
|---------------|---------------|-------------------|
| Patient Safety | 🔴 Critical Risk | 🟢 Acceptable |
| Regulatory Compliance | 🔴 Non-Compliant | 🟢 Compliant |
| Clinical Accuracy | 🟠 Moderate Risk | 🟢 Acceptable |
| Medication Safety | 🔴 Critical Risk | 🟢 Acceptable |

### Final Recommendation

**⚠️ NOT RECOMMENDED FOR CLINICAL USE** until Priority 1 issues are resolved.

Engage clinical pharmacists and physicians to validate all clinical decision support algorithms before production deployment. Consider obtaining HIPAA compliance certification and DEA certification for controlled substance prescribing.

---

## Appendix A: Files Reviewed

### Clinical Workflow Files

- `src/hooks/useDrugInteractionChecker.ts`
- `src/hooks/usePrescriptionSafety.ts`
- `src/components/prescriptions/DoseAdjustmentCalculator.tsx`
- `src/components/prescriptions/PediatricDosingCard.tsx`
- `src/components/prescriptions/PrescriptionSafetyAlerts.tsx`
- `src/components/doctor/PrescriptionBuilder.tsx`
- `src/components/nurse/VitalSignsForm.tsx`
- `src/hooks/useMedicationReconciliation.ts`
- `src/hooks/useCriticalValueAlerts.ts`

### Medical Coding Files

- `src/hooks/useICD10Codes.ts`
- `src/hooks/useCPTCodes.ts`
- `src/hooks/useLoincCodes.ts`

### Backend Functions

- `supabase/functions/drug-interaction-check/index.ts`
- `supabase/functions/lab-critical-values/index.ts`

---

## Appendix B: Regulatory References

- **21 CFR 1306** - Prescriptions for controlled substances
- **HIPAA** - Health Insurance Portability and Accountability Act
- **Joint Commission NPSG.03.06.01** - Medication reconciliation
- **CMS ICD-10-CM** - Clinical modification coding guidelines
- **AMA CPT** - Current Procedural Terminology standards
- **LOINC** - Logical Observation Identifiers Names and Codes

---

**Document Version**: 1.0  
**Generated**: January 2025  
**Classification**: Internal Use Only - Clinical Safety Audit
